StockData
Climb Bio, Inc. logo

Climb Bio, Inc. (CLYM) stock

CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$9.30−0.48 (-4.91%)

Close on Nov 18, 2026Market cap $534.16MP/E –Yield –

Climb Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Climb Bio's market cap was $703.59M on Nov 11, 2026, against $128.87M a year earlier. Over the last 5 years it ranged from $68.01M to $788.60M, with a median of $121.00M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$703.59M+158.0%
2025Dec 31, 2025$272.74M+125.4%
2024Dec 31, 2024$121.00M+63.2%
2023Dec 29, 2023$74.16M-23.9%
2022Dec 30, 2022$97.50M-64.4%
2021Dec 31, 2021$274.04M–

More Climb Bio figures

See a number that looks wrong?